Focus
Drug Discovery Investors: Angels and VC Firms
The RaiseHunt database lists 4,683 Drug Discovery investors: 239 angel investors and 4,444 people at 1,313 firms. Most list Seed and Series A among their stages; the largest hubs are New York, San Francisco and Boston.
Strongest in New York, San Francisco and Boston
- 4,683
- Drug Discovery investors
- 239
- Angel investors
- 4,444
- People at VC/PE firms
- 1,313
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
4,683 Drug Discovery investors
Showing 601-620
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
Nurdan Aydin Investment Partner at Novo Nordisk | Holbæk, Denmark | Corporate VC | Healthcare | View profile | |
Zsuzsanna Kerémi Vice President, EMEA Inclusive & Sustainable Ventures at Morgan Stanley | Budapest, Hungary | Corporate VCPrivate equity | FinTechHardware | View profile | |
Odile Jiang Investment Manager/投资经理 at Fosun Pharma | Shanghai, China | Corporate VC | AIHealthcare | View profile | |
Benjamin Gordon Affiliated at Alternative Investment Management | New York, United States | Family Office | HardwareHealthcare | View profile | |
Maria Eduarda Teixeira Investor at Eurofarma | São Paulo, Brazil | Corporate VC | Healthcare | View profile | |
Brian Owusu Growth and Venture Capital Investor at Morgan Stanley | San Francisco, United States | Corporate VCPrivate equity | FinTechHardware | View profile | |
Jane Yang Investor at Shenzhen Guozhong Venture Capital Management | United States | Venture capital | AIClimate | View profile | |
Devina Choudhary Angel Investor at LVX | Mumbai, India | Syndicate / Angel groupVenture capital | HealthcareSaaS | View profile | |
Axel Haverkamp Pharma Venture Manager bei Bayer Pharmaceuticals at Bayer | Fohlenplacken, Germany | Corporate VC | ClimateFood | View profile | |
Bard Geesaman Investor at MPM BioImpact | Boston, United States | Private equityVenture capital | Healthcare | View profile | |
Ishan Sinha Investor at Point72 | New York, United States | Private equityVenture debt | AIClimate | View profile | |
KV Prasad Investor at Featherlite | Vishakhapatnam, India | Operator-led | Healthcare | View profile | |
Madeleine Bell Head of Operations at Entrepreneurs First | London, United Kingdom | AcceleratorVenture capital | AIHardware | View profile | |
YunJeong Kim Affiliated at Ebest | Seoul, South Korea | Private equityVenture debt | AIHealthcare | View profile | |
Jayanth Batchu Associate/EIR at Xontogeny | Boston, United States | AcceleratorVenture capital | Healthcare | View profile | |
Michael Kowalski Mission-Related Investments Coordinator at Alzheimer's Drug Discovery Foundation | Brooklyn, United States | Venture capital | Healthcare | View profile | |
Shanshan Z. Assistant President(Investment) at Fosun Pharma | Shanghai, China | Corporate VC | AIHealthcare | View profile | |
Jiawei Zhang 中国人民保险 PICC at Picc Group | Xicheng Qu, China | Corporate VC | AIFinTech | View profile | |
Matthew Stannard Angel Investor/Board Member at Angel Investor Forum | New Haven, United States | AcceleratorSyndicate / Angel group | AIClimate | View profile | |
Connie H. Investor at Fosun Pharma | Germany | Corporate VC | AIHealthcare | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal
